Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters

Journal of Nutritional Biochemistry

Volumn 18, Issue 2, 2007, Pages 105-112

  Wilson, Thomas A ^a   Nicolosi, Robert J ^a   Woolfrey, Benjamin ^a   Kritchevsky, David ^b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Aortic cholesterol; Ferulic acid; Oryzanol; Plasma cholesterol; Rice bran oil

Indexed keywords

ALLOCHOLESTEROL; ALPHA TOCOPHEROL; CAMPESTEROL; CHOLESTEROL; CHOLESTEROL ESTER; COCONUT OIL; COPROSTANONE; COPROSTEROL; FERULIC ACID; GAMMA ORYZANOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTANOL; SITOSTEROL; STIGMASTEROL; UNCLASSIFIED DRUG; VEGETABLE OIL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; FECES LEVEL; FOOD INTAKE; HAMSTER; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPID COMPOSITION; NONHUMAN; RICE BRAN; STATISTICAL ANALYSIS; SYRIAN HAMSTER; VITAMIN BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; AORTA; CHOLESTEROL; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; COUMARIC ACIDS; CRICETINAE; GAMMA-TOCOPHEROL; HYPERCHOLESTEROLEMIA; LIPIDS; MESOCRICETUS; PHENYLPROPIONATES; PLANT OILS; WEIGHT GAIN;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 33845970605     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.03.006     Document Type: Article

References (69)

1. The Expert Panel. Report of the National Cholesterol Education Program Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148 (1988) 36-64
2. Keys A., Anderson J.T., and Grande R. Prediction of serum cholesterol responses of man to changes in fats in the diet. Lancet 2 (1957) 959
3. Hegsted D.M., McGandy R.B., Myers M.L., and Stare F.J. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 17 (1965) 281-295
4. Mattson F.H., and Grundy S.M. Comparison of effects of dietary saturated, monounsaturated, and poly-unsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 26 (1985) 194-202
5. Mensink R.P., and Katan M.B. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 321 (1989) 436-441
6. 2 and prostacyclin production in healthy young men. Am J Clin Nutr 50 (1989) 1382-1388
7. Dreon D.M., Vranizan K.M., Drauss R.M., Austin M.A., and Wood P.D. The effects of polyunsaturated fat vs. monounsaturated fat on plasma lipoproteins. JAMA 263 (1990) 2462-2466
8. Brousseau M.E., Stucchi A.F., Vespa D.B., Schaefer E.J., and Nicolosi R.J. A diet enriched in monounsaturated fats decreases low density lipoprotein concentrations in cynomolgus monkeys by a different mechanism than does a diet enriched in polyunsaturated fats. J Nutr 123 (1993) 2049-2058
9. Brousseau M.E., Stucchi A.F., Vespa D.B., Schaefer E.J., and Nicolosi R.J. Diets enriched in unsaturated fatty acids enhance apolipoprotein A-1 catabolism but do not affect either its production or hepatic mRNA abundance in cynomolgus monkeys. Atherosclerosis 115 (1995) 107-119
10. Pollak O.J., and Kritchevsky D. Sitosterol. In: Clarkson T.B., Kritchevsky D., and Pollak O.J. (Eds). Monographs on atherosclerosis (1981), Karger, New York 1-215
11. Grundy S.M., and Mok H.Y.I. Determination of cholesterol absorption in man. J Lipid Res 18 (1977) 263-271
12. Lees A.M., Mok H.Y.I., Lees R.S., and McCluskey M.A. Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 28 (1977) 325-338
13. Heinemann T., Leiss O., and von Bergmann K. Effect of low dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 61 (1986) 219-223
14. Best M.M., Duncan C.H., Van Loon E.J., and Walthen J.D. Lowering of serum cholesterol by the administration of a plant sterol. Circulation 10 (1954) 201-206
15. Hassan A.S., and Rampone A.J. Intestinal absorption and lymphatic transport of cholesterol and β-sitostanol in the rat. J Lipid Res 20 (1979) 646-653
16. Chandler R.F., Hooper S.N., and Ismail H.A. Anti-hypercholesterolemic studies with sterols: β-sitosterol and stigmasterol. J Pharmac Sci 68 (1979) 245-247
17. Qureshi A.A., Qureshi N., Wright J.J.K., Shen Z., Kramer A., Gapor A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 53 (1991) 1021S-1026S
18. Qureshi A.A., Burger W.C., Elson C.E., and Peterson D.M. The structure of an inhibitor of cholesterol biosynthesis isolated from barley. J Biol Chem 261 (1986) 10544-10550
19. Qureshi A.A., Crenshaw T.D., Abuirmeileh N., Peterson D.M., and Elson C.E. Impact of minor plant constituents on porcine hepatic lipid metabolism. Atherosclerosis 64 (1987) 109-114
20. Qureshi A.A., Burger N.C., Elson C.D., and Peterson D.M. Effects of cereals and culture filtrate of Trichoderma viride on lipid metabolism in swine. Lipids 17 (1982) 924-928
21. 2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr 53 (1991) 1042S-1046S
22. Kiribuchi M., Miura K., Tokuda S., and Kaneda T. Hypocholesterolemic effect of triterpene alcohols with soysterol on plasma cholesterol in rats. J Nutr Sci Vitaminol 29 (1983) 35-43
23. Sakamoto K., Tabata T., Shirasaki K., Inagaki T., and Nakayama S. Effects of gamma-oryzanol and cycloartenol ferulic acid ester on cholesterol diet induced hyperlipidemia in rats. Jpn J Pharmacol 45 (1987) 559-565
24. Yoshino G., Kazumi T., Amano M., Takiewa M., Yamasaki T., Takashima S., et al. Effects of gamma-oryzanol and probucol on hyperlipidemia. Curr Ther Res 45 (1989) 975-982
25. Sasaki J., Takada Y., Kusuda M., Tanabe Y., Matsunaga A., and Arakawa K. Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. Clin Ther 12 (1990) 263-268
26. Shinomiya M., Morisaki N., Matsuoka N., Izumi Y., Saito A., Kumagai A., et al. Effects of gamma-oryzanol on lipid metabolism in rats fed high-cholesterol diet. Tohoku J Exp Med 141 (1983) 191-197
27. Nicolosi R.J., Rogers E.J., Ausman L.M., and Orthoefer F.T. Rice bran oil and its health benefits. In: Marshall W., and Wadsworth J. (Eds). Rice science and technology (1992), Marcel Dekker, Inc, New York 421-437
28. Sayre B., and Saunders R. Rice bran and rice bran oil. Lipid Technol 2 (1990) 72-76
29. Rukmini C., and Raghuram T.C. Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review. J Am Coll Nutr 10 (1991) 593-601
30. Sugano M., and Tsuji E. Rice bran oil and cholesterol metabolism. J Nutr 127 (1997) 521S-524S
31. Wilson T.A., Ausman L.M., Lawton C.W., Hegsted M., and Nicolosi R.J. Comparative cholesterol lowering properties of vegetable oils: beyond fatty acids. J Am Coll Nutr 19 (2000) 601-607
32. Sharma R.D., and Rukmini C. Rice bran oil and hypocholesterolemia in rats. Lipids 21 (1986) 715-717
33. Seetharamaiah G.S., and Chandrasekhara N. Studies on hypocholesterolemic activity of rice bran oil. Atherosclerosis 78 (1989) 219-223
34. Nicolosi R.J., Ausman L.M., and Hegsted D.M. Rice bran oil lowers serum total and low density lipoprotein cholesterol and Apo B levels in nonhuman primates. Atherosclerosis 88 (1991) 133-142
35. Raghuram T.C., Rao U.B., and Rukmini C. Studies on the hypolipidemic effects of dietary rice bran oil in human subjects. Nutr Rep Int 39 (1989) 889-895
36. Lichtenstein A.H., Ausman L.M., Carrasco W., Gaultieri L.J., Jenner J.L., Ordovas J.M., et al. Rice bran oil consumption and plasma lipid levels in moderately hypercholesterolemic humans. Atheroscler Thromb 14 (1994) 549-556
37. Terpstra A.H.M., Holmes J.C., and Nicolosi R.J. The hypercholesterolemic effect of soybean protein vs. casein in hamsters fed cholesterol-free or cholesterol enriched semipurified diets. J Nutr 121 (1991) 944-947
38. Krause B.R., Bousley R.F., Kieft K.A., and Stanfield R.L. Effect of the ACAT inhibitor CI-976 on plasma cholesterol concentrations and distribution in hamsters fed zero- and low-cholesterol diets. Clin Biochem 25 (1992) 371-377
39. Rong N., Ausman L.M., and Nicolosi R.J. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipid 32 (1997) 303-309
40. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
41. Bucolo G., and David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19 (1973) 476-482
42. Weingand K.W., and Daggy B.P. Quantitation of high-density lipoprotein cholesterol in plasma from hamsters by differential precipitation. Clin Chem 36 (1990) 575
43. Mihaljevic B., Katusin-Razem B., and Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med 21 (1996) 53-63
44. Delaney B., Nicolosi R.J., Wilson T.A., Carlson T., Frazer F., Zheng G.-H., et al. β-Glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. J Nutr 133 (2003) 468-495
45. Rudel L.L., Kelley K., Sawyer J.K., Shah R., and Wilson M.M. Dietary monosaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol 18 (1998) 1818-1827
46. Snedecor G.W., and Cochran W.G. Statistical methods (1980), The Iowa State University Press, Ames, IA
47. Nicolosi R.J., Stucchi A.F., Kowala M.C., Hennessy L.K., Hegsted D.M., and Schaefer E.J. Effect of dietary fat saturation and cholesterol on LDL composition and metabolism. Atheroscler Thromb 10 (1990) 119-128
48. Kuo P.C., Rudd M.A., Nicolosi R.J., and Loscalzo J. Effect of dietary fat saturation and cholesterol on low density lipoprotein degradation by mononuclear cells of Cebus monkeys. Atheroscler Thromb 9 (1989) 919-927
49. Spady D.K., and Dietschy J.M. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest 81 (1988) 300-309
50. Spady D.K., and Dietschy J.M. Dietary saturated fat triacylglycerols suppress hepatic low density lipoprotein receptors in hamsters. Proc Natl Acad Sci U S A 82 (1985) 4526-4530
51. Most M.M., Tulley R., Morales S., and Lefevre M. Rice bran oil, not fiber, lowers cholesterol in humans. Am J Clin Nutr 81 (2005) 64-68
52. Berger A., Rein D., Schafer A., Monnard I., Gremaud G., Lambelet P., et al. Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur J Nutr 44 (2005) 163-173
53. Yoshino G., Kazumi T., Amano M., Takeiwa M., Yamasaki T., Takashima S., et al. Effects of γ-oryzanol on hyperlipidemic subjects. Curr Ther Res 45 (1989) 543-552
54. Seetharamaiah G.S., and Chandrasekhara N. Hypocholesterolemic activity of oryzanol in rats. Nutr Rep Int 38 (1988) 927-935
55. Nakamura H. Effect of γ-oryzanol on hepatic cholesterol biosynthesis and fecal excretion of cholesterol metabolites. Radioisotopes 15 (1966) 371-374
56. Rong N., Ausman L.M., and Nicolosi R. Rice bran oil decreases plasma LDL cholesterol by inhibiting dietary cholesterol absorption. FASEB J 8 (1994) 371-374 Abstract 162
57. Sharma R.D., and Rukmini C. Hypocholesterolemic activity of nonsaponifiable matter of rice bran oil. Indian J Med Res 85 (1987) 278-281
58. Graf E. Antioxidant potential of ferulic acid. Free Radic Biol 13 (1992) 435-448
59. Nystrom L., Makinen M., Lampi A.M., and Piironen V. Antioxidant activity of seryl ferulate extracts from rye and wheat bran. J Agric Food Chem 53 (2005) 2503-2510
60. Andreasen M.F., Landbo A.K., Christensen L.P., Hansen A., and Meyer A.S. Antioxidant effects of phenolic rye (Secale cereale L.) extracts, monomeric hydroxycinnamates, and ferulic acid dehydrodimers on human low-density lipoproteins. J Agric Food Chem 49 (2001) 4090-4096
61. Yagi K., and Ohishi N. Action of ferulic acid and its derivatives as antioxidants. J Nutr Sci Vitaminol 25 (1979) 127-130
62. Xu Z., and Godber J.S. Antioxidant activities of major components of γ-oryzanol from rice bran using a linoleic acid model. J Am Oil Chem Soc 78 (2001) 645-649
63. Xu Z., Hua N., and Godber J.S. Antioxidant activity of tocopherols, tocotrienols, and γ-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-azobis(2-methylpropionamidine) dihydrochloride. J Agric Food Chem 49 (2001) 2077-2081
64. Kikuzaki H., Hisamoto M., Hirose K., Akiyama K., and Taniguchi H. Antioxidant properties of ferulic acid and its related compounds. J Agric Food Chem 50 (2002) 2161-2168
65. Harwood Jr. H.J., Chandler C.E., Pellarin L.D., Bangerter F.W., Wilkins R.W., Long C.A., et al. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin β-tigogenin cellobioside (CP-88818; tiqueside). J Lipid Res 34 (1993) 377-395
66. Subbian M., and Ravi T. Dietary plant sterol: current status in human and animal sterol metabolism. Am J Clin Nutr 26 (1973) 219-225
67. Fujiwara S., Noumi K., Sugimoto I., and Awata N. Mass fragmentographic determination of ferulic acid in plasma after oral administration of γ-oryzanol. Chem Pharm Bull 30 (1982) 973-979
68. Vissers M.N., Zock P.L., Meijer G.W., and Katan M.B. Effect of plant sterols from rice bran oil and triterpene alcohols from sheanut oil on serum lipoprotein concentrations in humans. Am J Clin Nutr 72 (2000) 1510-1515
69. Trautwein E.A., Schulz C., Rieckhoff D., Kunath-Rau A., Erbersdobler H.F., Arjan de Groot W., et al. Effect of esterified 4-desmethylsterols and -stanols or 4,4′-dimethylsterols on cholesterol and bile acid metabolism in hamsters. Br J Nutr 87 (2002) 227-237